GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Trinity Biotech plc
Trinity Biotech is an Irish diagnostic testing company. Its stock price reflects its struggle for growth and profitability in a competitive market. The chart is a history of transformation efforts and the introduction of new, successful products.
Share prices of companies in the market segment - Medanalysis
Trinity Biotech is an Irish company that develops, manufactures, and markets diagnostic tests for infectious diseases, diabetes, and other conditions. We've categorized it as a "Medanalysis" company. The chart below shows how the market values companies in the laboratory diagnostics sector.
Broad Market Index - GURU.Markets
Trinity Biotech is an Irish company that develops, manufactures, and markets diagnostic tests for infectious and autoimmune diseases. As a significant player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Trinity's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
TRIB - Daily change in the company's share price Trinity Biotech plc
Trinity Biotech plc's daily price change reflects volatility in the medical diagnostics sector. The indicator demonstrates sensitivity to sales of its infectious disease and diabetes tests.
Daily change in the price of a set of shares in a market segment - Medanalysis
Trinity Biotech plc is a medical diagnostics company. This chart shows the sector's high volatility. Comparing it to TRIB, with its broad portfolio of tests, helps assess its stability compared to companies dependent on a single product.
Daily change in the price of a broad market stock, index - GURU.Markets
Trinity Biotech is an Irish company that produces diagnostic tests for infectious and autoimmune diseases. Its shares bring the dynamism of the European medtech sector to the US market. These international factors complicate the overall volatility picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Trinity Biotech plc
Trinity Biotech plc's year-over-year performance tells the story of its diversified medical diagnostics business. Its market capitalization change over the past 12 months reflects both the robust sales of its diabetes and infectious disease tests and its struggle to maintain profitability and manage its broad but complex product portfolio.
Annual dynamics of market capitalization of the market segment - Medanalysis
Trinity Biotech plc is an Irish company that develops and manufactures diagnostic tests. The chart shows how its diversified portfolio, competition, and dependence on diagnostic demand influence its performance in the medical testing sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Trinity Biotech, a diagnostic testing maker, reflects the global healthcare landscape with its performance. Its shares can sharply outperform the market during pandemics or surges in demand for certain tests. In calmer times, its performance demonstrates how stable and predictable its business is compared to the volatility of the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Trinity Biotech plc
Trinity Biotech produces diagnostic tests. Its monthly growth reflects both stable sales of its existing products and expectations for new developments. Quarterly revenue reports and regulatory approval announcements are the main drivers.
Monthly dynamics of market capitalization of the market segment - Medanalysis
This chart reflects the dynamics of the medical diagnostics sector. For Trinity, a diversified manufacturer, it serves as a backdrop. Its movements reflect demand for its tests for infectious and other diseases, as well as its efforts to adapt to the changing market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Trinity Biotech is an Irish company that produces diagnostic tests for labs and point-of-care use. This full-market chart allows you to assess how investors weigh Trinity's stable but slowly growing business against more innovative players in the diagnostics sector, and how this compares to overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Trinity Biotech plc
Trinity Biotech, a diagnostic testing maker, is responding to global health news. Its weekly stock price reflects demand for tests for infectious diseases, including HIV, as well as tests for monitoring diabetes, a chronic problem in many countries.
Weekly dynamics of market capitalization of the market segment - Medanalysis
Trinity Biotech, like other diagnostic testing manufacturers, is dependent on overall healthcare trends. Demand for diagnostics for infectious and chronic diseases is a common factor. The chart shows how Trinity, with its diversified portfolio, performs relative to the industry average.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Trinity Biotech, as a healthcare company, can demonstrate defensive qualities while moving out of sync with the broader market. Demand for its diagnostic tests is less dependent on economic cycles than that of industrial giants. The chart will help assess whether TRIB truly is a safe haven during periods of general market turbulence.
Market capitalization of the company, segment and market as a whole
TRIB - Market capitalization of the company Trinity Biotech plc
Trinity Biotech's market capitalization tells the story of its diagnostics business. The company produces tests for infectious diseases and diabetes. Its valuation chart reflects how investors view its product portfolio, competition, and ability to bring new diagnostic solutions to market.
TRIB - Share of the company's market capitalization Trinity Biotech plc within the market segment - Medanalysis
Trinity Biotech is an Irish company that develops and manufactures diagnostic tests for various diseases, including infectious diseases and diabetes. Its market share in the medical analytics sector reflects its broad product portfolio. The chart shows the company's share of the global laboratory diagnostics market.
Market capitalization of the market segment - Medanalysis
Trinity Biotech produces diagnostic tests for infectious diseases, diabetes, and other conditions. The chart below shows the market capitalization of the medical analysis sector. This represents the value of a vital industry that provides physicians with information for decision-making.
Market capitalization of all companies included in a broad market index - GURU.Markets
Trinity Biotech is an Irish company that produces diagnostic tests for various diseases, including diabetes and HIV. Its market capitalization reflects its position in the in-vitro diagnostics market. The chart below shows the economic weight of the medical testing industry.
Book value capitalization of the company, segment and market as a whole
TRIB - Book value capitalization of the company Trinity Biotech plc
Trinity Biotech's material foundation is diagnostic testing. The Irish company's book value reflects its factories, which produce tests for diabetes, infectious diseases, and autoimmune disorders, as well as its R&D centers. The chart below shows how this industry veteran manages its global manufacturing base.
TRIB - Share of the company's book capitalization Trinity Biotech plc within the market segment - Medanalysis
Trinity Biotech manufactures diagnostic tests at its own facilities. These production sites are its main material asset. The S_BCap_Seg graph shows the company's share of the medical testing infrastructure.
Market segment balance sheet capitalization - Medanalysis
Trinity Biotech produces medical diagnostic tests. This business requires certified laboratories and production lines for reagents and devices. The book value chart shows how investments in these knowledge-intensive assets shape its business.
Book value of all companies included in the broad market index - GURU.Markets
Trinity Biotech's assets include global diagnostic testing production. The company's book value reflects its factories in Ireland and the United States, where tests for HIV, diabetes, and infectious diseases are manufactured. This material base enables the company to supply critical diagnostic tools to more than 100 countries.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Trinity Biotech plc
Trinity Biotech manufactures and sells diagnostic tests. Its balance sheet reflects its production capacity and R&D. Its market capitalization is a measure of its portfolio of tests (e.g., for HIV and diabetes), its distribution network, and its ability to compete in the medical diagnostics market.
Market to book capitalization ratio in a market segment - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests. The company owns manufacturing and research facilities. The chart shows how the market values its product portfolio and research relative to the book value of its assets.
Market to book capitalization ratio for the market as a whole
Trinity Biotech develops, manufactures, and markets diagnostic tests. The company combines scientific research and manufacturing capabilities. Its valuation is a balance between innovation and business stability. The chart shows how the market values this diversified player in the medical diagnostics sector.
Debts of the company, segment and market as a whole
TRIB - Company debts Trinity Biotech plc
Trinity Biotech, a diagnostic test maker, uses debt to fund production and research. This chart shows how the company is investing in developing new tests, such as those for infectious diseases, and maintaining production capacity to meet demand from laboratories and hospitals.
Market segment debts - Medanalysis
Trinity Biotech is an Irish company that produces diagnostic tests for infectious and other diseases. The medical diagnostics market is highly competitive, requiring companies to continually invest in developing new, more accurate tests. This chart shows how the company funds the development and production of its products to maintain its market position.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Trinity Biotech plc
Trinity Biotech develops and manufactures diagnostic tests for medical use. This chart shows its reliance on debt capital. For a company in the medical diagnostics industry, debt can finance the development of new tests or the expansion of production capacity, which is especially important amid global healthcare challenges.
Market segment debt to market segment book capitalization - Medanalysis
Trinity Biotech develops and manufactures medical diagnostic tests. This chart for the medical diagnostics sector shows how companies finance their R&D and manufacturing capabilities. It allows one to assess how aggressively the company invests in the development of new tests in a highly competitive and regulatory environment.
Debt to book value of all companies in the market
Trinity Biotech develops, manufactures, and markets diagnostic tests for the medical sector. Demand for its products is driven by healthcare spending. The debt-to-book value chart below is an indicator of overall economic health, which impacts hospital and laboratory budgets and, consequently, Trinity Biotech's test purchase volumes.
P/E of the company, segment and market as a whole
P/E - Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for infectious diseases, diabetes, and other conditions. This chart reflects the global diagnostics market. The dynamics of this indicator depend on demand for its tests, competition, and the success of new diagnostic product launches, which drive its revenue.
P/E of the market segment - Medanalysis
Trinity Biotech plc operates in the medical diagnostics sector. This chart shows the average P/E ratio for this industry. Comparing a company's P/E to this ratio helps understand whether the market considers its testing portfolio and geographic presence more or less attractive than those of other diagnostic equipment manufacturers.
P/E of the market as a whole
Trinity Biotech develops, manufactures, and markets diagnostic tests for medical use. The company has a broad product portfolio, ranging from infectious disease tests to diabetes tests. This chart reflects the state of the healthcare sector. The company's valuation depends on its ability to compete with major players in the diagnostics market and introduce new, in-demand tests.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for medical use. The chart shows future revenue expectations, which depend on demand for tests (e.g., for infectious diseases) and the company's ability to bring new diagnostic products to market in a competitive environment.
%20P%2FE%20Trinity%20Biotech%20plc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Trinity-Biotech-plc&v=1772550374336 "Chart of the company's future (projected) P/E Trinity Biotech plc")
Future (projected) P/E of the market segment - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests for clinical laboratories and home use. This chart shows how its future revenue expectations compare to the industry average, reflecting its diversified product portfolio and the competitive landscape of the diagnostics market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Medanalysis&v=1772550374420 "Future (projected) P/E graph of the market segment - Medanalysis")
Future (projected) P/E of the market as a whole
Trinity Biotech is an Irish company that produces diagnostic tests for infectious diseases and diabetes. Demand for its products is relatively stable, but the company faces intense competition. Given overall market forecasts, Trinity prioritizes the innovation and effectiveness of its tests.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772550374439 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Trinity Biotech plc
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for clinical laboratories and for direct patient use. The company's profits depend on sales of tests for infectious diseases, diabetes, and other conditions. This chart shows how demand for diagnostics and competition in the medical testing market impact financial performance.
Profit of companies in the market segment - Medanalysis
Trinity Biotech plc is an Irish company that develops and manufactures diagnostic tests for clinical laboratories and self-testing. This chart reflects the profitability of the healthcare analytics sector. A broad portfolio of tests, from infectious diseases to diabetes, makes its financial results reflective of global trends in diagnostics and healthcare.
Overall market profit
Trinity Biotech manufactures and sells diagnostic tests for clinical laboratories. Demand for its products, particularly for tests to monitor diabetes and infectious diseases, is relatively stable. This makes the company's business less sensitive to economic cycles, as can be seen in this chart, as the need for diagnostics is always present.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for clinical laboratories and home use. The future profit projections shown in this chart depend on sales volumes of tests for infectious diseases, diabetes, and other conditions. It reflects analyst expectations regarding demand for diagnostic products in the healthcare sector.
%20profit%20of%20the%20company%20Trinity%20Biotech%20plc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Trinity-Biotech-plc&v=1772550374540 "Graph of future (projected) profit of the company Trinity Biotech plc")
Future (predicted) profit of companies in the market segment - Medanalysis
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for clinical laboratories and point-of-care use. This chart shows profitability forecasts for the healthcare analytics sector. It reflects expected demand for diagnostics for infectious and other diseases.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Medanalysis&v=1772550374557 "Graph of future (predicted) profits of companies in a market segment - Medanalysis")
Future (predicted) profit of the market as a whole
Trinity Biotech develops and manufactures diagnostic tests. Demand for medical diagnostics is generally stable, but growth and the introduction of new tests depend on healthcare system budgets. The overall profit forecast, shown in the graph, reflects the economic ability of governments and clinics to invest in modern medicine.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772550374565 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Trinity Biotech plc
Trinity Biotech plc develops and manufactures diagnostic tests for medical laboratories. Revenue depends on sales of tests and equipment. The price-to-sales ratio (P/S) reflects how investors value its product portfolio, including infectious disease tests, and the stability of demand for them.
P/S market segment - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests and equipment for clinical laboratories and physician practices. Their products cover a variety of areas, from infectious diseases to diabetes. This chart shows how the market values their diversified product portfolio and their share of the global medical diagnostics market.
P/S of the market as a whole
Trinity Biotech develops, manufactures, and markets diagnostic tests for the medical sector. The company's revenue depends on demand for its tests in hospitals and laboratories worldwide. This chart shows the average revenue estimate, which helps understand how the market values the revenue of an established company in the medical diagnostics sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for clinical laboratories and for patient use. This chart shows how investors estimate future revenue, which depends on demand for tests for infectious diseases, diabetes, and other conditions, as well as competition in the diagnostics industry.
%20P%2FS%20Trinity%20Biotech%20plc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Trinity-Biotech-plc&v=1772550374620 "The graph of the company's future (projected) P/S Trinity Biotech plc")
Future (projected) P/S of the market segment - Medanalysis
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for clinical laboratories and physicians. This chart shows how the market estimates its future diagnostic sales. It compares it to other companies in the medical testing sector, reflecting demand for its tests and its competitive position.
%20P%2FS%20market%20segment%20graph%20-%20Medanalysis&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Medanalysis&v=1772550374634 "Future (projected) P/S market segment graph - Medanalysis")
Future (projected) P/S of the market as a whole
Trinity Biotech develops and manufactures diagnostic tests for various diseases. Its products are used in laboratories and hospitals worldwide. This chart shows overall investor revenue forecasts, and TRIB demonstrates how the medical diagnostics sector plays a key role in the healthcare system, generating stable demand.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772550374638 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Trinity Biotech plc
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for the medical market. This chart shows revenue from sales of a wide range of tests, including rapid tests for infectious diseases and laboratory tests for the diagnosis of diabetes and autoimmune disorders.
Sales of companies in the market segment - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests. This chart segments its revenue by segment, such as infectious disease, diabetes, and autoimmune tests. This allows investors to assess which diagnostic market is most important to the company.
Overall market sales
Trinity Biotech develops, manufactures, and markets diagnostic tests. Demand for medical diagnostics is generally stable and independent of economic cycles. This overall market performance chart is not key for Trinity, as the demand for diagnostics is driven by public health, not the economy.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for clinical laboratories. Its revenue forecast depends on demand for tests for infectious diseases, diabetes, and other conditions. This chart shows how analysts assess its product portfolio and competition in the medical diagnostics market.
%20sales%20of%20the%20company%20Trinity%20Biotech%20plc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Trinity-Biotech-plc&v=1772550374659 "Schedule of future (projected) sales of the company Trinity Biotech plc")
Future (projected) sales of companies in the market segment - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests. This chart shows projected revenue for the entire medical analytics sector. It reflects demand for tests to diagnose infectious diseases, autoimmune diseases, and diabetes, which is key to assessing the market potential of Trinity Biotech's product line.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Medanalysis&v=1772550374665 "Schedule of future (projected) sales of companies in the market segment - Medanalysis")
Future (projected) sales of the market as a whole
Trinity Biotech develops, manufactures, and markets diagnostic tests for medical use. Demand for its products depends on testing volumes in hospitals and laboratories. This dynamic of overall economic expectations impacts healthcare system budgets. During periods of growth, clinics may increase their purchases of consumables and upgrade their diagnostic equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772550374680 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for medical and laboratory use. This chart shows how the company competes in the medical device market. Its profitability depends on sales of tests for infectious diseases, diabetes, and other conditions.
Market segment marginality - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests and equipment for clinical laboratories and home use. This chart shows the average profit margin in the medical diagnostics sector. It helps understand how Trinity's product portfolio and global presence impact its financial performance compared to the industry average.
Market marginality as a whole
Trinity Biotech plc develops and manufactures diagnostic tests for medical use. Demand for its products depends on the needs of the healthcare system. This overall profitability chart shows the economic backdrop, but demographic trends, disease prevalence, and laboratory budgets are more important for Trinity Biotech.
Employees in the company, segment and market as a whole
Number of employees in the company Trinity Biotech plc
Trinity Biotech develops, manufactures, and markets diagnostic tests for the medical market. The company's staff is engaged in R&D, manufacturing, and global sales. This chart reflects the scale of its operations, supplying hospitals and laboratories with tests for infectious diseases, diabetes, and other conditions.
Share of the company's employees Trinity Biotech plc within the market segment - Medanalysis
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for the medical market. This chart shows its contribution to the global diagnostics industry. It reflects the significant share of biochemists, quality control specialists, and manufacturing personnel developing tests for infectious diseases, diabetes, and other conditions that Trinity Biotech employs.
Number of employees in the market segment - Medanalysis
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for clinical laboratories. This chart shows employment in the medical analytics sector. The growth in the number of specialists in this field reflects the increasing volume of laboratory testing and the demand for rapid and accurate diagnostic tests for various diseases.
Number of employees in the market as a whole
Trinity Biotech plc develops, manufactures, and markets diagnostic tests for the medical sector. Diagnostics are a key element of modern medicine, enabling the early detection of diseases. This graph reflects overall employment, and growth in the medical testing sector indicates the development of the healthcare system.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Trinity Biotech plc (TRIB)
Trinity Biotech produces diagnostic tests. It combines R&D, manufacturing, and regulatory expertise. The metric on this chart reflects how the market values all of these competencies. It represents the value of patents, production lines, and the team's ability to obtain regulatory approvals per employee.
%20of%20the%20company%20Trinity%20Biotech%20plc%20(TRIB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Trinity-Biotech-plc-TRIB&v=1772550374793 "Chart of market capitalization per employee (in thousands of dollars) of the company Trinity Biotech plc (TRIB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Medanalysis
Trinity Biotech produces tests and equipment for medical diagnostics. In this industry, market value per employee reflects production efficiency and market share of its products. Comparisons with other diagnostic companies help assess its technological advancement and commercial success.
%20by%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Medanalysis&v=1772550374810 "Market capitalization per employee (in thousands of dollars) by market segment - Medanalysis")
Market capitalization per employee (in thousands of dollars) for the overall market
Trinity Biotech develops, manufactures, and sells diagnostic tests for the medical market. This business requires both scientific development and efficient manufacturing. This chart shows how the market evaluates the company's ability to develop new tests and manufacture them according to strict medical standards.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772550374813 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Trinity Biotech plc (TRIB)
Trinity Biotech manufactures and sells diagnostic tests (laboratory and rapid) for diabetes, infectious diseases, and autoimmune diseases. This is a competitive B2B market. This chart shows how efficiently the company manages its production and R&D, generating profit from the sale of these consumables.
%20Chart%20Trinity%20Biotech%20plc%20(TRIB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Trinity-Biotech-plc-TRIB&v=1772550374820 "Company Profit Per Employee (in thousands of dollars) Chart Trinity Biotech plc (TRIB)")
Profit per employee (in thousands of dollars) in the market segment - Medanalysis
Trinity Biotech develops, manufactures, and markets diagnostic tests for the medical sector. This chart is an indicator of operational and commercial performance. It reflects how successfully the company produces and markets its tests, from infectious disease tests to diabetes tests, generating profits in the competitive global medical diagnostics industry.
%20in%20the%20market%20segment%20-%20Medanalysis&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Medanalysis&v=1772550374834 "Chart of profit per employee (in thousands of dollars) in the market segment - Medanalysis")
Profit per employee (in thousands of dollars) for the market as a whole
Trinity Biotech plc develops and manufactures in-vitro diagnostic tests for laboratories and home use (e.g., HIV and diabetes tests). This metric reflects the efficiency of their R&D and production. It demonstrates how successfully the company competes in the diagnostics market, generating profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772550374848 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Trinity Biotech plc (TRIB)
Trinity Biotech, a manufacturer of infectious disease diagnostic tests, shows the efficiency of its manufacturing and commercial operations in this chart. Revenue per employee depends on diagnostic kit sales volumes. This trend can fluctuate significantly depending on the global epidemiological situation.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Trinity-Biotech-plc-TRIB&v=1772550374855 "Sales chart per company employee Trinity Biotech plc (TRIB)")
Sales per employee in the market segment - Medanalysis
Trinity Biotech (TRIB) is an Irish company that develops and manufactures diagnostic tests for laboratories and point-of-care clinics, including tests for diabetes and infectious diseases. This chart shows the average revenue per employee in the segment. Comparing TRIB to this benchmark demonstrates how effectively their manufacturing and R&D generate diagnostic test sales.
Sales per employee for the market as a whole
Trinity Biotech (TRIB) is a company that produces diagnostic tests (both lab and rapid tests). This metric reflects the efficiency of their production and R&D. It can be volatile: for example, COVID-19 tests temporarily boosted the metric, but now the company should be generating revenue from its core portfolio.
Short shares by company, segment and market as a whole
Shares shorted by company Trinity Biotech plc (TRIB)
Trinity Biotech is an Irish company that produces diagnostic tests (including tests for HIV, diabetes, and COVID). The company is struggling with debt and declining revenue. This chart shows the bets that the company will not survive. "Bears" believe that its tests are outdated and the COVID boom has passed, leaving the company with financial problems.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Trinity-Biotech-plc-TRIB&v=1772550374903 "Short Shares Chart for the Company Trinity Biotech plc (TRIB)")
Shares shorted by market segment - Medanalysis
Trinity Biotech (TRIB) is an Irish manufacturer of diagnostic tests, including for diabetes and HIV. This chart highlights the pessimism in the medical diagnostics sector. The growing short position in the industry is a bet that competition from giants and pricing pressure from insurance companies are eroding margins. Investors doubt TRIB will be able to sell its tests profitably.
Shares shorted by the overall market
Trinity Biotech is a veteran in the diagnostics industry. When this indicator of *general* market pessimism rises, it exacerbates investors' *specific* fears. They fear that unprofitable, highly leveraged companies like TRIB won't survive a recession, and so they become the first to sell off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Trinity Biotech plc (TRIB)
Trinity Biotech produces medical diagnostic tests for labs and home use (for example, tests for diabetes or infections). This business can be either stable or explosive. This indicator shows the "temperature" of demand. It can remain "cool" for a long time and then "overheat" during health crises.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Trinity-Biotech-plc-TRIB&v=1772550374916 "RSI 14 indicator chart for the company's stock Trinity Biotech plc (TRIB)")
RSI 14 Market Segment - Medanalysis
Trinity Biotech is an Irish company that develops and manufactures diagnostic tests. Their products are used to detect infectious diseases, diabetes, and autoimmune disorders. This chart reflects the overall sentiment in the medical testing and diagnostics sector, helping to assess the overall market sentiment toward this industry.
RSI 14 for the overall market
Trinity Biotech (TRIB) develops diagnostic tests. This graph is its lifeline. Its business is pure R&D. During periods of euphoria, investors are willing to fund the "future of medicine." In moments of panic, they flee unprofitable biotech companies, and TRIB risks being left without funds for its breakthrough but expensive research.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TRIB (Trinity Biotech plc)
Trinity Biotech is an Irish company that develops and manufactures diagnostic tests for laboratories and clinics, focusing on diabetes (HbA1c) and infectious diseases (HIV). This chart shows the average 12-month price target from analysts, reflecting their view on test sales volumes and competition.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TRIB-Trinity-Biotech-plc&v=1772550374983 "A chart showing analyst consensus forecasts for the expected stock price. TRIB (Trinity Biotech plc)")
The difference between the consensus estimate and the actual stock price TRIB (Trinity Biotech plc)
Trinity Biotech is an Irish company that produces diagnostic tests (including HIV and diabetes tests). This chart shows the difference between the market valuation and the consensus forecast. It shows how confident experts are in their R&D portfolio and business restructuring.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TRIB-Trinity-Biotech-plc&v=1772550374994 "A chart showing the difference between the consensus forecast and the actual stock price. TRIB (Trinity Biotech plc)")
Analyst consensus forecast for stock prices by market segment - Medanalysis
Trinity Biotech is an Irish company that produces laboratory diagnostic tests (diabetes, HIV, autoimmune). This chart shows analysts' overall expectations for the medical testing sector. It reflects whether experts believe the "traditional" laboratory diagnostics market will grow or decline.
Analysts' consensus forecast for the overall market share price
Trinity Biotech is an Irish company that produces laboratory diagnostic tests and point-of-care tests for a wide range of conditions (diabetes, HIV). This chart shows overall market sentiment. For Trinity, which operates in the defensive healthcare sector, overall optimism is important, but their business is also valued for its stability during periods of market pessimism.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Trinity Biotech plc
Trinity Biotech is a diagnostics veteran. This Irish company produces standard diagnostic tests (laboratory reagents) for diabetes, HIV, and autoimmune diseases. This chart is a summary indicator of their turnaround. It reflects their stable but stagnant legacy business and their desperate struggle to remain profitable.
AKIMA Market Segment Index - Medanalysis
Trinity Biotech (TRIB) is an Irish diagnostic testing company. They produce tests for infectious diseases (HIV), diabetes (HbA1c), and autoimmune disorders. The chart shows the average index for the segment, helping investors assess how well Trinity Biotech competes in the medical testing market compared to the average.
The AKIM Index for the overall market
Trinity Biotech is an Irish diagnostics company specializing in tests for diabetes (HbA1c), HIV, and autoimmune diseases. This chart, reflecting the market average, provides context. It helps assess how Trinity Biotech, which is undergoing a transformation and introducing CGM (glucose monitoring), compares to overall macroeconomic trends.
